MDR-TB care at 12 tertiary level hospitals in Punjab, Islamabad and AJK (Oct 01, 2012 to Jun 30, 2015)

MDR-TB care at 12 tertiary level hospitals in Punjab, Islamabad and AJK (Oct 01, 2012 to Jun 30, 2015)

MDR-TB care arrangements and practices vary widely across teaching hospitals; hospital premises, equipment, supplies and staff strengthened for offering quality MDR-TB care as per program-endorsed protocols.

  • Location: Ten hospitals in Punjab; and one hospital each in Islamabad and Muzafarabad (AJK) districts.
  • Activities:
    • Arrange premises, including infection control, for outpatient and inpatient MDR-TB care;
    • Strengthened hospital diagnostics for MDR-TB care (e.g. GeneXpert); also link hospitals with a reference laboratory for drug sensitivity testing.
    • Arrange MDR-TB drugs (through National TB Program); also enhance hospital ability to store and manage MDR-TB drugs;
    • Recruit additional medical and allied staff (i.e. 8 person); and train the hospital and project staff for MDR-TB care at each participating hospital
    • Deliver program-endorsed MDR-TB care, free-of-charge, at each participating hospital
    • Enable and engage rural health centers and secondary hospitals for delivering community-based MDR-TB care
    • Maintain patient records; also monitor and support the hospital and community based care (by facility/project staff)
    • Manage social support for each registered MDR-TB patient and his/her supporter (i.e. food pack and travel reimbursement on each monthly follow-up visit to a hospital)
  • Outputs:
    • outpatient and inpatient premises and drug storage enhanced for MDR-TB care at 12 public tertiary hospitals
    • 96 project staff added (trained & supported) for MR-TB care at 12 hospitals.
    • 120 doctors and 120 allied staff at tertiary hospitals trained and supported for MDR-TB care, as per program protocols
    • 612 doctors and 787 allied staff at (sub) district hospitals and rural health centers got trained on MDR-TB care.
    • 2,226 MDR-TB cases diagnosed, registered and being treated
    • More than 60% treatment success achieved among registered MDR-TB patients